Amgen Inc. (NASDAQ: AMGN, SEHK: 4332) is an international biotechnology company headquartered in Newbury Park, California. Amgen is the largest independent biotech firm, with approx. 15,000 staff members in 2005. Its products include EPOGEN, ARANESP, ENBREL, Kineret, Neulasta, NEUPOGEN, and Sensipar / Mimpara. EPOGEN and NEUPOGEN (the company's first products to hit the market) were the two most successful biopharmaceutical products at the time of their respective releases.
BusinessWeek (as cited in "References") ranked Amgen fourth on the S&P 500 for being the most "future-oriented" of those five hundred corporations.[1] BusinessWeek ostensibly calculated the ratio of research and development spending, combined with capital spending, to total outlays; Amgen had the fourth highest ratio, at 506:1000. Amgen is the largest employer in Thousand Oaks and second only to the United States Navy in terms of number of people employed in Ventura County.
Amgen is a member of the Pennsylvania Bio commerce organization, though it appears not to maintain a facility in Pennsylvania (United States).[2]
2006-09-05 03:22:27
·
answer #1
·
answered by Smokey 5
·
5⤊
0⤋
Yes, it's a commodity like gold or oil or pig's bellies. They use amgen to make dental floss. It's the essential ingredient. If you think that people will be flossing a lot, then you should buy amgen.
2006-09-05 11:55:06
·
answer #2
·
answered by Yardbird 5
·
0⤊
1⤋
Amgen is not a commodity. It is a biotech company.
Amgen Inc. (stock symbol AMGN) trades on the NASDAQ stock exchange.
If you go to Yahoo finance at
finance.yahoo.com, you can type in the symbol and see the stock price, and learn all about the company! (IF you want to) :-)
Hope that helps!
2006-09-05 13:10:58
·
answer #3
·
answered by Yada Yada Yada 7
·
0⤊
0⤋